Focus on assisted reproductive technology (ART)
First written in FY2023. 1 of 3 entries say "Restated". Latest entry: 2026-05-12.
0 other companies' latest entry also says "Advanced".
- 2026-05-12AdvancedEarnings presentation
「This is a culture medium for embryo cultivation based on a new concept that uses antibodies to suppress a protein involved in declining embryo quality.」
In the ART field, the company specifically described its research on an embryo culture medium and its novel mechanism of action. - FY2024RestatedAnnual report
「In addition, we launched a tissue culture medium for in vitro fertilization in 2000 and entered the assisted reproductive technology (ART) field. In 2017, we consolidated the brand under “HiGROW,” with the aim of contributing to couples struggling with infertility and, ultimately, to measures addressing Japan’s declining birth rate, a critical issue facing the country.」
The company continues to pursue a policy of positioning the ART field and “Nurturing life” as social themes. - FY2023First statedAnnual report
「In addition, we launched a tissue culture medium for in vitro fertilization in 2000 and entered the assisted reproductive technology (ART) field. In 2017, we consolidated the brand under “HiGROW,” with the aim of contributing to couples struggling with infertility and, ultimately, to measures addressing Japan’s declining birth rate, a critical issue facing the country. For many years, we have operated our business under the banner “Supporting life,” with an emphasis on establishing a stable supply system. Following our full-scale entry into the ART field, we added “Nurturing life” and have been actively pursuing initiatives toward the realization of a sustainable society.」
The company positions in vitro fertilization tissue culture media and the ART field as a social theme, “Nurturing life,” in addition to “Supporting life,” which represents its traditional focus on stable supply.